Cargando…
Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase
Cancer is a leading cause of death worldwide. The search for innovative therapeutic approaches is a principal focus of medical research. Vaccine strategies targeting a number of tumor-associated antigens are currently being evaluated. To date, none have garnered significant success. Purportedly, an...
Autores principales: | Wirsching, Sebastian, Fichter, Michael, Cacicedo, Maximiliano L., Landfester, Katharina, Gehring, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604227/ https://www.ncbi.nlm.nih.gov/pubmed/36293298 http://dx.doi.org/10.3390/ijms232012444 |
Ejemplares similares
-
An innovative cell selection approach in developing human cells overexpressing aspartyl/asparaginyl β-hydroxylase
por: Bakhtiari, Hadi, et al.
Publicado: (2020) -
OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cells
por: Wirsching, Sebastian, et al.
Publicado: (2022) -
Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function
por: Silbermann, Elizabeth, et al.
Publicado: (2010) -
Aspartyl-(asparaginyl) β-Hydroxylase, Hypoxia-Inducible Factor-1α and Notch Cross-Talk in Regulating Neuronal Motility
por: Lawton, Margot, et al.
Publicado: (2010) -
Design, development and production of nano-particle-based anticancer vaccine targeting human aspartyl (asparaginyl) β-hydroxylase (HAAH)
por: Biswas, Biswajit, et al.
Publicado: (2013)